Phama Company Shares Rise Ahead of FDA Review
01 Novembre 2021 - 4:09PM
AllPennyStocks.com
After a surprising rejection in August, two pharma companies are
working toward approval ahead of their Type A meeting with the FDA
for a drug with significant potential
Medexus...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Medexus Pharmaceuticals (TSX:MDP)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Medexus Pharmaceuticals (TSX:MDP)
Storico
Da Nov 2023 a Nov 2024